Crossmark

Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis

Crossref DOI link: https://doi.org/10.1186/s12879-018-3661-0

Published Online: 2019-01-07

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matulionytė, Raimonda https://orcid.org/0000-0003-4791-3133
Žagminas, Kęstutis

Balčiūnaitė, Eglė

Matulytė, Elžbieta

Paulauskienė, Rasutė

Bajoriūnienė, Almina

Ambrozaitis, Arvydas
Funding

Funding for this research was provided by:

AbbVie (Not applicable)
License Information

Text and Data Mining valid from 2019-01-07
More Information

Article History

Received: 13 March 2018

Accepted: 26 December 2018

First Online: 7 January 2019

Ethics approval and consent to participate

: Ethics approval was obtained from the Lithuanian Bioethics Committee. The ethics approval number is 158200–5–056-10. Consent for HIV screening was incorporated into the patient’s general informed consent for medical care on the same basis as other screening or diagnostic tests, and its written form was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.